The coronavirus disease 2019 caused by a new type of coronavirus has been emerging from China and led to thousands of death globally since December 2019. Despite many groups have engaged in studying the newly emerged virus and searching for the treatment of COVID-19, the understanding of the COVID-19 target -ligand interactions represents a key challenge. Herein, we introduce COVID-19 Docking Server, a web server that predicts the binding modes between COVID-19 targets and the ligands including small molecules, peptide and antibody. Structures of proteins involved in the virus life cycle were collected or constructed based on the homologs of coronavirus, and prepared ready for docking. The platform provides a free and interactive tool for the prediction of COVID-19 target-ligand interactions and following drug discovery for COVID-19.
INTRODUCTION
According the situation report from World Health Organization (WHO), more than 75,000 cases of coronavirus disease 2019 (COVID-19) have been reported among 25 countries till February 21, 2020. As the first COVID-19 case was reported in Wuhan city, Hubei province of China in December 2019, concentrated pneumonia occurred in China, especially in Wuhan. The pathogen caused the disease was soon identified as a novel coronavirus, which belongs to the genus Betacoronavirus and is closely related to severe acute respiratory syndrome coronavirus (SARS-CoV) with 89.1% nucleotide similarity in the viral genome 1, 2 . Later on, it was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on the Taxonomy of Viruses. Tremendous effects have been done to study the newly emerged virus and find potent drugs for clinical usage. Wang et. al from Wuhan Institute of Virology screened some of the FDA approved anti-virus or anti-infection drugs and found that remdesivir and chloroquine could effectively inhibit the virus in cell based assay with EC50 of 0.77 and 1.13 μM, respectively 3 . Several clinical trials are ongoing for the treatment of COVID-19. However, no drug or vaccine has yet been approved.
In a very short time, the structures of functional proteins essential for SARS-CoV-2 were achieved by groups in China, including the main protease and spike protein in binding with angiotensin-converting enzyme 2 (ACE2). Although the structures of other proteins remain unknown, the high amino acid identity between SARS-CoV-2 and SARS-CoV (77.2%) enables that it is possible to establish the homology modeled structures of SARS-CoV-2 based on the protein structures of SARS-CoV with high confidence. Thus, we built and collected the protein structures as potential targets of SARS-CoV-2 according to those of SARS-CoV. A web-server, COVID-19 Docking Server, was constructed to facilitate people to evaluate the binding modes and binding affinities between these targets and small molecules, peptides as well as antibodies. By launching the server, we'd like to provide a free and easy to use tool for people who is interested in drug discovery against COVID-19.
METHODS AND MATERIALS

Protocol of COVID-19 Docking Server
The flow chart of the COVID-19 Docking Server is shown in Figure 1 . For small molecule docking, Autodock Vina 4 is used as docking engine. Two computational type are provided with the default computational type as "Docking" (D) to dock single small molecule to the target, and the other option "Screening" (S) to dock a number of small molecules to the target. The protein structures of COVID-19 targets were extracted and prepared by MGLTools 1.5.6. User only needs to upload the small molecules in smi, mol2 or sdf formats. Open Babel was used for format transformation or 3D coordinate generation for the uploaded files 5 . Then ligand_prepare.py from MGLTools 1.5.6 is used to convert the ligand files into pdbqt format with Gasteiger charge added. The box center for docking was defined according to the information of active sites or binding sites of its homologs of SARS-CoV. All the parameters are set as default except the exhaustiveness value is set to 12 to achieve higher accuracy. 
COVID-19 Targets in the server
The structures of functional or structural proteins of SARS-CoV-2 were collected or built based on its homologs of coronavirus by using homology modeling module of Maestro 10 (www.schrodinger.com). All the targets were prepared and available for peptides or antibodies docking on the website. For small molecule docking, the docking box was carefully defined for every specific target. Only the targets with enzyme active site, substrate binding site or inhibitor binding site were prepared and set for small molecule docking. The detailed information about the targets is described as below.
Nonstructural proteins
Main protease (Mpro): It is also named as chymotrypsin-like protease (3CLpro). 
Structure proteins
Spike protein (S protein):
The surface spike glycoprotein is consisting of three S1-S2 heterodimers. The receptor binding domain (RBD) located on the head of S1 and bind with the cellular receptor angiotensin-converting enzyme 2 (ACE2), initiating the membrane fusion of the virus and host cell. Recently, the structure of spike RBD of SARS-CoV-2 in complex with human ACE2 was released by Wang and Zhang's group in Tsinghua University. The structure was downloaded and prepared for protein docking.
We also built the monomer and trimer structure of full length spike protein based on 6ACG and prepared for protein docking 13 . 
S2 of S protein:
Envelop small membrane protein (E protein):
It forms pentamer and functions as ion channel, also named as E channel. The structure of E channel was built based on 5X29 15 . Both the monomer and the pentamer were prepared for protein docking. And the E channel structure was also prepared for small molecule docking with the center of ion channel defined as box center in docking.
Membrane protein (M protein):
The M protein involves in most of protein-protein interactions required for assembly of coronaviruses and it is also determined as a protective antigen in humoral responses 16 . The structure of M protein was built by using I-TASSER server and prepared for protein docking [17] [18] [19] . 
RESULTS AND DISCUSSION
Usage of small molecule docking
For each job of small molecule docking, the user can choose one of the COVID-19
targets. The small molecules should be uploaded in strict smi, mol2 or sdf formats. The user needs to choose the computational modes before uploading the small molecule files:
if "Docking" is selected, only one small molecule should be uploaded, and top 10 binding modes will be displayed on the result page. If "screening" is selected, 10-20 molecules should be uploaded, and the top 10 molecules ranked by the scoring function will be displayed on the result page. If 1-10 molecules need to be evaluated, then the user has to upload the molecules one by one and choose the "Docking" mode. After the submission, an email will be sent to user's email address, containing a directed link to access the docking results. After the job completes, the user could enter the job ID to access the result page. By default, the server only displays the top 10 models. The selected COVID-19 protein target is renamed as Input_R.pdb. The top 10 models are named as TopL1.pdb-TopL10.pdb, respectively. The scored file is named as Score.dat. The models are visualized in 3D by JSmol and the user can view and download the docking results from the result page.
Here, we take Papain-like protease and its inhibitor as an example for small molecule docking 7 . The "Docking" mode was selected and the mol2 format of its inhibitor in PDB 4OW0 was uploaded as ligand. For the top rank binding modes, the predicted binding energies of Top 1 and 2 were -11.5 kcal/mol and -10.7 kcal/mol, and the L_RMSDs were 0.23Å and 3.60 Å, respectively. As shown in Figure 4A , the best binding mode of the inhibitor is very similar to the complex structure.
Usage of peptide and antibody docking
Similar to small molecule docking, the user needs to choose the COVID-19 protein target and uploads ligand protein (peptide or antibody) in strict pdb format for peptide or antibody docking. The protein docking server can perform global docking and sitespecific docking to predict the binding mode between COVID-19 protein target and peptide (or antibody). The user could enter one residue into either the receptor box or the ligand box, or he could enter one residue into receptor box and one into the ligand box simultaneously. If only one residue on the ligand or receptor is defined, then the conformations with the specific residue on the interface of the complex are retained.
When the user defines one residue on the receptor and the other one on the ligand simultaneously, then he needs to choose the constraint type: ambiguous constraints 13 or multiple constraints. When the "ambiguous constraints" is selected, the conformations are retained with at least one selected residue on the interface. When the "multiple constraints" is selected, the conformations are retained with both of the residues on the interface.
We use the post-fusion state of S2 segment of spike protein as an example for peptide docking. The receptor is 5-helices structure extracted from the post-fusion state of 6helices S2. One helix was extracted from the S2 structure and used as ligand peptide.
The pdb file of ligand peptide was uploaded and the default global docking mode was chosen. In our example, the predicted binding energies of Top 1 and 2 binding modes were -532.3 kcal/mol and -374.3 kcal/mol, and the L_RMSDs were 0.77 Å and 2.62 Å, respectively. As shown in Figure 4B , the best binding mode is very similar to the 6helices structure of spike protein. 
CONCLUSION
The structures of potential targets of COVID-19 were collected or built based on the homology structures of coronavirus. An online interactive server, COVID-19 Docking Server, was constructed to predict the binding modes between the targets and small molecules, peptides or antibodies by implement of Autodock Vina and CoDockPP as docking engines. The server provides a user-friendly interface and binding mode visualization for the results, which makes it a useful tool for drug discovery of COVID-19.
